Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform 2024-01-09 00:00
Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market 2024-01-08 22:28
WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site 2024-01-08 22:00
Akeso to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Share Its Corporate & Innovative Clinical Development Roadmap 2024-01-08 21:38
YS Biopharma Announces Changes to its Board Committees 2024-01-08 21:00
Novel Technology Transforms Baldness Treatment Using Beard and Body Hair 2024-01-08 21:00
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries 2024-01-08 20:30
The World's First Clinical Base Editing Therapy for Hemoglobinopathy 2024-01-08 19:46
Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC) 2024-01-08 19:35
So-Young Announces Update on Repurchase and Cancellation of Shares 2024-01-08 19:00
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts 2024-01-08 17:52
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report 2024-01-08 16:00
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa 2024-01-08 15:30
Caliway Announces FDA Acceptance of CBL-514 IND Application for Placebo-Controlled Phase 2 Study to treat Dercum's Disease 2024-01-08 13:25
2024 Trend Forecast for Cosmetic Surgery & Medical Aesthetics in Singapore 2024-01-08 09:00
Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023 2024-01-08 09:00
Suvoda Announces 30% Growth in 2023 Driven by Strong Customer Adoption of New Suvoda Platform and Products 2024-01-08 08:00
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis 2024-01-08 07:00
Supplemental New Drug Application for Akeso's Cadonilimab (PD-1/CTLA-4) Accepted by NMPA for First-line Treatment of Gastric Cancer 2024-01-05 21:00
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio 2024-01-05 19:44
1 106 107 108 109 110 963